default author photo

Ana Maria Henao Restrepo

Independent

United States

World Health Organization (WHO)

SCHOLARLY PAPERS

2

DOWNLOADS

302

TOTAL CITATIONS

9

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Considerations in Boosting COVID Vaccine Immune Responses

Number of pages: 7 Posted: 30 Aug 2021
Philip Krause, Thomas Fleming, Richard Peto, Ira Longini, John Peter Figueroa, Jonathan Sterne, Alejandro Cravioto, Helen Rees, Julian Higgins, isabelle Boutron, Narendra Arora, Fatema Kazi, Rogerio Gaspar, Soumya Swaminathan, Michael Ryan and Ana Maria Henao Restrepo
Government of the United States of America - Food and Drug Administration (FDA), Independent, University of Oxford - Nuffield Department of Population Health, University of Florida - Department of Biostatistics, University of the West Indies (Mona), University of Bristol, Facultad de Medicina, Universidad Nacional Autónoma de México, University of the Witwatersrand - Reproductive Health and HIV Research Unit (RHRU), University of Bristol - Department of Population Health Sciences, Universite Paris Descartes, Independent, World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), Independent and Independent
Downloads 200 (380,469)
Citation 9

Abstract:

Loading...

COVID vaccines, boosting, efficacy

2.

Rvsv-Zebov Vaccination in People with Pre-Existing Immunity to Ebolavirus: An Open-Label Safety and Immunogenicity Study in Guinean Communities Affected by Ebola Virus Disease (L’Essai Proches)

Number of pages: 18 Posted: 09 May 2024
Conall H. Watson, Pierre-Stéphane Gsell, Yper Hall, Anton Camacho, Ximena Riveros, Godwin Enwere, Andrea Vicari, Séverine Danmadji Nadlaou, Alhassane Toure, Ismaila M. Sani, Abdourahamane Diallo, Aboubacar Barry, Cece Kolie, Sophie Duraffour, Andre Maomou, Kassie Dore, Honora A. Djidonou, Aminata Bagayoko, Philos P. Damey, Mabetty Camara, Fatoumata Battouly Diallo, Thierno Oumar Fofana, Kalidou Toure, Mohamed Diaby, Lansana Sylla, Doussou Conde, Ibrahima Lansana Kaba, Tom Tipton, Rosalind M. Eggo, Michael Marks, Chrissy H. Roberts, Thomas Strecker, Stephan Günther, Sakoba Keita, W. John Edmunds, Miles W. Carroll and Ana Maria Henao Restrepo
UK Health Security Agency, World Health Organization (WHO), UK Health Security Agency, Epicentre (Paris), World Health Organization (WHO), World Health Organization (WHO), Pan American Health Organization, World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), Bernhard-Nocht-Institute for Tropical Medicine (BNITM), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), Gamal Abdel Nasser University, World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), University of Oxford - Pandemic Sciences Institute, London School of Hygiene & Tropical Medicine - Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine - Department of Clinical Research, London School of Hygiene & Tropical Medicine, University of Marburg, Bernhard-Nocht-Institute for Tropical Medicine (BNITM), World Health Organization (WHO), London School of Hygiene & Tropical Medicine, University of Oxford - Wellcome Trust Centre for Human Genetics and Independent
Downloads 102 (679,608)

Abstract:

Loading...

Ebola virus disease, Ebola, vaccine, rVSV-ZEBOV, safety, immunogenicity, cohort study